Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[These results suggest that PAK1 is essential for the malignant growth of NF2-deficient cells, and that PAK1-blocking drugs could be potentially useful forthe treatment of neurofibromatosis types 2, in addition to Ras-induced cancers and neurofibromatosis type 1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP261903.RAbW2jmc83S4kOQUjW97fVIICnWHJjSnGoMk4Knyxpfac130_assertion description "[These results suggest that PAK1 is essential for the malignant growth of NF2-deficient cells, and that PAK1-blocking drugs could be potentially useful forthe treatment of neurofibromatosis types 2, in addition to Ras-induced cancers and neurofibromatosis type 1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP261903.RAbW2jmc83S4kOQUjW97fVIICnWHJjSnGoMk4Knyxpfac130_provenance.
• NP792432.RAtZWZUHrWQBcuGsLQuJwAFRCiBfJ2Sjk5g4jhi-4ait4130_assertion description "[These results suggest that PAK1 is essential for the malignant growth of NF2-deficient cells, and that PAK1-blocking drugs could be potentially useful forthe treatment of neurofibromatosis types 2, in addition to Ras-induced cancers and neurofibromatosis type 1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP792432.RAtZWZUHrWQBcuGsLQuJwAFRCiBfJ2Sjk5g4jhi-4ait4130_provenance.
• NP350392.RAeMxm7oNwqdxfZ8prT_Zpiz0QP_uswNWXXmrtqGZe3nU130_assertion description "[These results suggest that PAK1 is essential for the malignant growth of NF2-deficient cells, and that PAK1-blocking drugs could be potentially useful forthe treatment of neurofibromatosis types 2, in addition to Ras-induced cancers and neurofibromatosis type 1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP350392.RAeMxm7oNwqdxfZ8prT_Zpiz0QP_uswNWXXmrtqGZe3nU130_provenance.
• NP270433.RAPs-9Dtx2g4OxQ5-OiiqOOLMz7hItXkEyrV3IMTWoc1o130_assertion description "[These results suggest that PAK1 is essential for the malignant growth of NF2-deficient cells, and that PAK1-blocking drugs could be potentially useful forthe treatment of neurofibromatosis types 2, in addition to Ras-induced cancers and neurofibromatosis type 1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP270433.RAPs-9Dtx2g4OxQ5-OiiqOOLMz7hItXkEyrV3IMTWoc1o130_provenance.
• NP643048.RAQFG8IqQ37WFq9VbVbvJie76XBYAdJkkZ1AAPnpcM39A130_assertion description "[These results suggest that PAK1 is essential for the malignant growth of NF2-deficient cells, and that PAK1-blocking drugs could be potentially useful forthe treatment of neurofibromatosis types 2, in addition to Ras-induced cancers and neurofibromatosis type 1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP643048.RAQFG8IqQ37WFq9VbVbvJie76XBYAdJkkZ1AAPnpcM39A130_provenance.
• assertion description "[These results suggest that PAK1 is essential for the malignant growth of NF2-deficient cells, and that PAK1-blocking drugs could be potentially useful forthe treatment of neurofibromatosis types 2, in addition to Ras-induced cancers and neurofibromatosis type 1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[These results suggest that PAK1 is essential for the malignant growth of NF2-deficient cells, and that PAK1-blocking drugs could be potentially useful forthe treatment of neurofibromatosis types 2, in addition to Ras-induced cancers and neurofibromatosis type 1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP434178.RAkzlPfxTmJ0iPiKhcswymUX8xaPf7A134KxUlqapROZE130_assertion description "[These results suggest that PAK1 is essential for the malignant growth of NF2-deficient cells, and that PAK1-blocking drugs could be potentially useful forthe treatment of neurofibromatosis types 2, in addition to Ras-induced cancers and neurofibromatosis type 1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP434178.RAkzlPfxTmJ0iPiKhcswymUX8xaPf7A134KxUlqapROZE130_provenance.
• NP434180.RAvNUIZ8F8dOvYM4qn6qqwetkUNwzoqG5HsxhDNnPXu74130_assertion description "[These results suggest that PAK1 is essential for the malignant growth of NF2-deficient cells, and that PAK1-blocking drugs could be potentially useful forthe treatment of neurofibromatosis types 2, in addition to Ras-induced cancers and neurofibromatosis type 1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP434180.RAvNUIZ8F8dOvYM4qn6qqwetkUNwzoqG5HsxhDNnPXu74130_provenance.
• NP608087.RA4v-S3FXDlH0o4zPZ_9Y61wPe7W31iD2pviqx2akZWqo130_assertion description "[These results suggest that PAK1 is essential for the malignant growth of NF2-deficient cells, and that PAK1-blocking drugs could be potentially useful forthe treatment of neurofibromatosis types 2, in addition to Ras-induced cancers and neurofibromatosis type 1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP608087.RA4v-S3FXDlH0o4zPZ_9Y61wPe7W31iD2pviqx2akZWqo130_provenance.